Transcatheter Aortic Valve Replacement (TAVR) in Low Risk Patients

Description:

The purpose of this study is to demonstrate that the safety and effectiveness of the Medtronic Transcatheter Aortic Valve Replacement (TAVR) system as measured by rates of all-cause mortality or disabling stroke at two years is non-inferior to Surgical Aortic Valve Replacement (SAVR) in the treatment of severe aortic stenosis in subjects who have a low predicted risk of operative mortality for SAVR.

This research study is led by Dr. Ashequl Islam.

Contact: Annette Scarnici, RN, CCRC, 413-794-9076

Participation details:

Start Date: March 01, 2016

IRB Number: 957848

Condition/Disease: Heart

Location: Baystate Medical Center, 759 Chestnut Street, Springfield, MA 01199

Eligibility:

At low risk for SAVR
Severe aortic stenosis

Time Commitment: Patients will be seen at pre and post-procedure, discharge, 30 days, and, 1 year.